Cell Counting Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Cell Counting Instrument Market is segmented by Product Type (Instruments and Consumables), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Cell Counting Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cell Counting Market Size

Cell Counting Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 7.20 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Cell Counting Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Cell Counting Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cell Counting Market Analysis

The Cell Counting Market is expected to register a CAGR of 7.2% during the forecast period.

COVID-19 had a significant impact on the adoption of cell-counting products and consumables. The pandemic witnessed increased adoption of cell counting devices, as osteopenia and lymphopenia were the potential indicators of COVID-19. The study, published in BMC Infectious Diseases in June 2021, found that in COVID-19 patients, a high WBC count upon admission was significantly linked to death. As a result, in the therapy of COVID-19, a higher WBC count should be given more consideration. Thus, the COVID-19 pandemic had a pronounced impact on the growth of the market. However, as the pandemic has subsided currently, the market is expected to experience stable growth over the forecast period of the study.

The major factors contributing to the market's growth are the rising incidence of target diseases like HIV, measles, diphtheria, and chronic diseases like cancer and other blood disorders; and the growing use of high-throughput flow cytometry and automated hematology analyzers.

According to the data from UNAIDS, in 2022, an estimated 38.4 million people worldwide were living with HIV, and an estimated 1.5 million people became newly infected with HIV in 2021. It was also stated that by 2021, 28.7 million people would have access to antiretroviral therapy. Thus, rising cases of infectious diseases are ultimately expected to increase the demand for cell counting products and consumables.

Furthermore, technological advancements in cell counting products and consumables have led to increased product launches and, thereby, increased adoption, in turn driving market growth. For instance, Logos Biosystems, a leading provider of cutting-edge life science solutions and a division of Aligned Genetics, Inc., officially launched the CountWire System in February 2021.

Therefore, the rising prevalence of chronic diseases, growing technological advancements, and product launches in the cell counting market, among others, are expected to drive the growth of this market. But the growth of the market is likely to be slowed by the high cost of advanced cell counting systems and product recalls of hematology analyzers.

Cell Counting Industry Overview

The cell counting market is moderately competitive. A few of the crucial approaches followed by players are product advancement, invention, acquisitions, and mergers. Some of the companies currently dominating the market are Danaher Corporation, Thermo Fisher Scientific, Becton, Dickinson and Company, Merck, Bio-Rad Laboratories, and GE Healthcare, among others.

Cell Counting Market Leaders

  1. Thermo Fisher Scientific

  2. Becton, Dickinson and Company

  3. Bio-Rad Laboratories

  4. Merck KGaA

  5. Danaher Corporation (Beckman Coulter, Inc.)

  6. *Disclaimer: Major Players sorted in no particular order
Cell Counting Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cell Counting Market News

  • March 2022: Mindray launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests.
  • February 2022: Abacus dx entered into a new partnership with Luminex for their Guava range of flow cytometry instruments and reagents. As part of the deal, Luminex's Guava line of flow cytometry instruments and reagents will be sold by Abacus dx.

Cell Counting Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Incidence of Target Diseases and Blood Disorders
    • 4.2.2 Growing Use of High-throughput Flow Cytometry and Automated Hematology Analyzers
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Advanced Cell Counting Systems and Product Recalls of Hematology Analyzers
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Instruments
    • 5.1.1.1 Spectrophotometers
    • 5.1.1.2 Flow Cytometers
    • 5.1.1.3 Hematology Analyzers
    • 5.1.1.4 Cell Counters
    • 5.1.2 Consumables
    • 5.1.2.1 Media, Sera, and Reagents
    • 5.1.2.2 Assay Kits
    • 5.1.2.3 Other Consumables
  • 5.2 Geography
    • 5.2.1 North America
    • 5.2.1.1 United States
    • 5.2.1.2 Canada
    • 5.2.1.3 Mexico
    • 5.2.2 Europe
    • 5.2.2.1 Germany
    • 5.2.2.2 United Kingdom
    • 5.2.2.3 France
    • 5.2.2.4 Italy
    • 5.2.2.5 Spain
    • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
    • 5.2.3.1 China
    • 5.2.3.2 Japan
    • 5.2.3.3 India
    • 5.2.3.4 Australia
    • 5.2.3.5 South Korea
    • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
    • 5.2.4.1 GCC
    • 5.2.4.2 South Africa
    • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
    • 5.2.5.1 Brazil
    • 5.2.5.2 Argentina
    • 5.2.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Danaher Corporation (Beckman Coulter Inc.)
    • 6.1.2 Thermo Fisher Scientific Inc.
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Merck KGaA
    • 6.1.5 Bio-Rad Laboratories Inc.
    • 6.1.6 GE Healthcare
    • 6.1.7 Agilent Technologies Inc.
    • 6.1.8 F. Hoffmann-La Roche
    • 6.1.9 Siemens Healthineers AG
    • 6.1.10 DeNovix Inc.
    • 6.1.11 PerkinElmer Inc.
    • 6.1.12 Tecan Group AG
    • 6.1.13 Sysmex Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cell Counting Industry Segmentation

As per the scope of the report, cell counting plays a vital role in cell analysis; it helps identify the viability of cells and cell growth; and it quantifies the number of live or dead cells in cell culture. The Cell Counting market is segmented by Product Type (Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, and Cell Counters) and Consumables (Media, Sera, and Reagents, Assay Kits, and Other Consumables)) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type Instruments Spectrophotometers
Flow Cytometers
Hematology Analyzers
Cell Counters
Consumables Media, Sera, and Reagents
Assay Kits
Other Consumables
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cell Counting Market Research FAQs

What is the current Cell Counting Market size?

The Cell Counting Market is projected to register a CAGR of 7.2% during the forecast period (2025-2030)

Who are the key players in Cell Counting Market?

Thermo Fisher Scientific, Becton, Dickinson and Company, Bio-Rad Laboratories, Merck KGaA and Danaher Corporation (Beckman Coulter, Inc.) are the major companies operating in the Cell Counting Market.

Which is the fastest growing region in Cell Counting Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Cell Counting Market?

In 2025, the North America accounts for the largest market share in Cell Counting Market.

What years does this Cell Counting Market cover?

The report covers the Cell Counting Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Cell Counting Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Cell Counting Industry Report

Statistics for the 2025 Cell Counting market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cell Counting analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.